Abstract:OBJECTIVE:Acute monocytic leukemia (AML)-M5 is the common type of acute myeloid leukemias in children. Studies have shown that there are abundant lipopolysaccharide (LPS) receptor (designated as CD14) molecules on the cell membrane of M5 cells and they play an important role in the diagnosis of M5, since they can be recognized and bound by mouse-anti-human CD14 monoclonal antibody (McAb). However, mouse-originated antibodies are largely not suitable for clinical application due to the severe side effects, thus "humanized antibody" is desired. As the first step for developing humanized antibody, the construction and expression of single chain antibody (scFv) with functional protein are necessary. The present study aimed to express ZCH-7-2F9 ScFv (scFv(2F9)) in eukaryotic cells and obtain the scFv(2F9) protein with a high biological activity.METHODS:Four primers were synthesized to construct the eukaryotic expressional vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. scFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Positive recombinants (pSectag2A/scFv(2F9)) were identified through enzyme cleaving and sequenced before expression and were transformed into Chinese hamster ovary (CHO) cells for expression. Western-Blot and flow cytometry (FCM) were carried out to determine the relative molecular mass (Mr) and binding activity of scFv(2F9).RESULTS:The cloned scFv(2F9) gene was identified to be functional by sequencing and expressing. The interested protein could be detected in the culture supernatant of transformed CHO cells with an Mr of 31 000. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.30% and 63.38%, respectively after blocking with scFv(2F9), while those were 4.55%, 10.09% and 5.02% after blockage using the supernatant from the CHO cells transfected with blanked vector pSectag2A.CONCLUSIONS:The scFv(2F9) against human CD14 antigen was successfully expressed in eukaryotic cells and showed a high biological activity, which may be useful for the further studies on its humanized antibodies.

Production and Identification of Monoclonal Antibodies to Chcd25

Production and Application of Monoclonal Antibodies to GST

Generation and Characterization of Monoclonal Antibodies Against Chicken Interleukin 4

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

[Construction, Expression and Identification of a Single Chain Antibody Variable (scfv) Against Human CD25 Molecule].

Development of monoclonal antibodies against chicken IFN-γ (chIFN-γ) and identification of their recognizing regions

Expression and Purification of Recombinant Anti-human CD25 Chimeric Monoclonal Antibody

Preparation,identification and preliminary application of monoclonal antibodies against recombinant human basic fibroblast growth factor

Prepartion and Identification of the Monoclonal Antibody to CTGF

Preparation and Characterization of the Monoclonal Antibody Against HSPC238 Antigen

Production and identification of monoclonal antibodies against recombinant TGEV M protein

Production and Characterization of a CD25-specific Scfv-Fc Antibody Secreted from Pichia Pastoris

Preparation and Identification of Monoclonal Antibody Against Human Cervical Cancer Oncogene

Preparation and Identification of Monoclonal Antibodies Against Humanin

Development of a Novel Functional Monoclonal Antibody to Human CD275: Characterization and Biological Activity.

Preparation of a functional monoclonal antibody against human 4-1BBL molecule and analysis of its biological characteristics

Production and Characterization of Monoclonal Antibody to Duck IL-2

Preparation and identification of integrin inhibitor AP25 monoclonal antibody

[Preparation and Characterization of a Novel Functional Anti-Human CD83 Monoclonal Antibody].

Production and application of monoclonal antibody against major histocompati-bility complex class Ⅰrelated chain A and B

Production of Monoclonal Antibody Against Human PCIA1 and Study on Its Characteristics